A18.12
Tuberculosis of bladder
Clinical Classification Guidelines
Medical Intelligence & Overview
Tuberculosis of the bladder is a rare form of urinary tract tuberculosis caused by the bacterium Mycobacterium tuberculosis. This infection primarily occurs when tuberculosis spreads from other parts of the body, such as the lungs, to the bladder. It can lead to significant discomfort and urinary problems if not diagnosed and treated promptly. Recognizing the symptoms and understanding the causes of this condition are essential steps toward effective management.
Causes & Symptoms
Clinical Causes: Spread of Mycobacterium tuberculosis from active lung or other TB sites via the bloodstream or lymphatic system to the bladder. Reactivation of latent tuberculosis infection in the urinary tract. Close contact with individuals who have active tuberculosis, especially if preventive measures are not taken. Inadequate or incomplete treatment of a prior tuberculosis infection, leading to persistent bacteria in the body. Compromised immune system, making it easier for tuberculosis to infect various organs. Presence of other urinary tract abnormalities or conditions that may predispose the bladder to infection.
Key Symptoms: Persistent or recurrent urinary frequency and urgency Pain or a burning sensation during urination Hematuria (blood in the urine) Lower abdominal pain or discomfort Cloudy or foul-smelling urine Fever, night sweats, or general malaise in some cases Urinary retention or difficulty emptying the bladder
Diagnostic & Treatment
Diagnosis Path: Diagnosis of tuberculosis of the bladder typically involves a combination of clinical evaluation and various tests. These may include urine analysis, urine cultures for Mycobacterium tuberculosis, imaging studies like ultrasound or cystoscopy, and histopathological examination of bladder tissue if biopsies are taken. Chest X-rays may also be performed to detect active or past pulmonary tuberculosis, which could be the source of spread.
Treatment Protocols: Treatment generally requires a long-term course of specific anti-tubercular medications, usually including isoniazid, rifampicin, ethambutol, and pyrazinamide. The duration of therapy can range from several months to a year, depending on the severity and response to treatment. Additional supportive measures, such as pain management and addressing any complicating factors, may be necessary. Regular monitoring is important to ensure the infection is fully cleared and to prevent relapse.
Clinical Advice & FAQs
Billing Guidance
Is A18.12 a billable ICD-10 code?
Yes, A18.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A18.12?
Clinical documentation must specify the nature of Tuberculosis of bladder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
